Option chain shows key data for Hauppauge Digital's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Hauppauge Digital.

Hauppauge Digital (OTC:HAUP) Stock, Option Chain

Hauppauge Digital Inc is a developer of analog and digital TV tuner and other products for the personal computer market. Its product portfolio covers USB TV tuners, HD video recorders, Internal TV tuners, Digital CableCARD tuners, Analog video capture products, European Digital TV Receivers and Digital media adapters, among others. The company has an international global presence.

Short Sellers

Education

Downgrades

Movers & Shakers

General

AVID

BODY

CHGS

CHMR

CPSL

CRMB

HAUP

kids

LDKSY

LIWA

LLEN

MBIS

NEWL

OCZTQ

PGRX

RMKR

SIEGY

TELK

30 Stocks Delisted So Far In 2014 

News

Intraday Update

Markets

BAXS

PBMD

Stocks Hitting 52-Week Lows

MRCC

QCCO

HAUPPAUGE DIGITAL INC by Hauppauge Digital, Inc.

Hauppauge Digital Inc

It is hard for a <a href="http://www.benzinga.com/trading-ideas/long-ideas/13/06/3677534/can-companies-recover-from-a-nasdaq-or-nyse-delisting">stock to recover</a> from a NASDAQ or NYSE delisting; although the process is seamless, getting to the point of being delisted is typically bad news.

	The company typically has lost so much value that it doesn&rsquo;t meet the exchange&#39;s minimum price requirements or has not filed required documents (e.g., quarterly reports). Here are some recent delist-ees in 2014.

	Crumbs Bake Shop

	Crumbs (OTC: <a class="ticker" href="/stock/crmb#OTC">CRMB</a>) is perhaps the most notable delisted stock this year. The cupcake producer announced bankruptcy in early July after rampant expansion led to unpayable debt. Marcus Lemonis, of CNBC&rsquo;s television program The Profit, expressed his interest in purchasing Crumb&rsquo;s assets following bankruptcy proceedings.

	NewLead Holdings

	The Greek company NewLead (OTC: <a class="ticker" href="/stock/newl#OTC">NEWL</a>) was booted from the NASDAQ in June for &ldquo;false and misleading statements,&rdquo; along with inability to keep its share price above $1. Investor confidence is so dire that two 50-for-1 splits could not keep the stock above $1. NewLead and fancier IronRidge Global are in litigation; according to NewLead, IronRidge owes $125 million.

	Related: <a href="http://www.benzinga.com/general/education/14/07/4734747/4-things-every-beginning-trader-should-know" title="4 Things Every Beginning Trader Should Know">4 Things Every Beginning Trader Should Know</a>

	L&amp;L Energy

	Although L&amp;L Energy (OTC: <a class="ticker" href="/stock/llen#OTC">LLEN</a>) chose to voluntarily delist, shares had already lost almost all of their value, and many were expecting the Nasdaq delisting. The GeoInvesting web site uncovered that the company was fraudulent, lying to investors about ownership of assets and on financial statements. L&amp;L Energy is yet another example of the need to be cautious about investing in Chinese reverse merger firms.

	Related: <a href="http://www.benzinga.com/trading-ideas/long-ideas/14/01/3014935/9-one-time-penny-stocks-didnt-stay-that-way">9 One-Time Penny Stocks That Didn&#39;t Stay That Way</a>

	Lihua International

	Lihua (OTC: <a class="ticker" href="/stock/liwa#OTC">LIWA</a>) is another fraudulent Chinese company. In this case, the CEO was diverting company assets to himself. As expected, the following sell-off was steep: Shares sold off more than 90 percent. Before being kicked off the NASDAQ, Lihua shares were halted as the exchange demanded more information.

	Kids Brands

	Kids Brands (OTC: KIDBQ) announced it would move to over-the-counter trading at the end of March, as the company could not maintain the $15 million market cap required by the New York Stock Exchange. In June Kids Brands announced it would pursue sale of assets in chapter 11 bankruptcy. The company has found a buyer for most of its brands.

	Siemens

	Siemens&#39; (OTC: <a class="ticker" href="/stock/siegy#OTC">SIEGY</a>) American depository shares were delisted from the New York Stock Exchange in May. According to the company, the main reason for the delisting is that very little of global equity trade was taking place in the United States (less than five percent). Shares are now traded OTC.

	Other stocks that have been delisted in 2014 include:
<ul>
<li>
		Telik (OTC: <a class="ticker" href="/stock/telk#OTC">TELK</a>)</li>
<li>
		Tandy Brands (OTC: TBACQ) - bankrupt</li>
<li>
		Hauppauge Digital (OTC: <a class="ticker" href="/stock/haup#OTC">HAUP</a>)</li>
<li>
		Avid Technology (OTC: <a class="ticker" href="/stock/avid#OTC">AVID</a>)</li>
<li>
		ZCO Liquidating (OTC: <a class="ticker" href="/stock/ocztq#OTC">OCZTQ</a>) - bankrupt</li>
<li>
		Rainmaker Systems (OTC: <a class="ticker" href="/stock/rmkr#OTC">RMKR</a>)</li>
<li>
		Prospect Global Resources (OTC: <a class="ticker" href="/stock/pgrx#OTC">PGRX</a>)</li>
<li>
		James River Coal (OTC: JRCCQ) - bankrupt</li>
<li>
		Coldwater Creek (OTC: CWTRQ) - bankrupt</li>
<li>
		Tri-Tech Holdings (OTC: TRITF)</li>
<li>
		China Precision Steel (OTC: <a class="ticker" href="/stock/cpsl#OTC">CPSL</a>)</li>
<li>
		Mediabistro (OTC: <a class="ticker" href="/stock/mbis#OTC">MBIS</a>)</li>
<li>
		Body Central (OTC: <a class="ticker" href="/stock/body#OTC">BODY</a>)</li>
<li>
		Ambient Corporation (OTC: <a class="ticker" href="/stock/abtg#OTC">ABTG</a>)</li>
<li>
		Cardium Therapeutics (OTC: CRXM)</li>
<li>
		Quaterra Resources (OTC: QTRRF)</li>
<li>
		Dolan (OTC: DOLNQ) - bankrupt</li>
<li>
		GSE Holdings (OTC: GSEHQ) - bankrupt</li>
<li>
		Chimera Energy (OTC: <a class="ticker" href="/stock/chmr#OTC">CHMR</a>)</li>
<li>
		LDK Solar (OTC: <a class="ticker" href="/stock/ldksy#OTC">LDKSY</a>)</li>
<li>
		Loncor Resources (OTC: LONCF)</li>
<li>
		Genco Shipping (OTC: GNKOQ) - bankrupt</li>
<li>
		China Gengsheng (OTC: <a class="ticker" href="/stock/chgs#OTC">CHGS</a>)</li>
<li>
		Ambow Education (OTC: AMBOY)</li>
</ul>

J. C. Penney Company (NYSE: <a class="ticker" href="/stock/jcp#NYSE">JCP</a>) shares fell 9.24% to reach a new 52-week low of $10.80 after Dow Jones reported that J.C. Penney will hire around 35,000 holiday season workers.

Prima Biomed (NASDAQ: <a class="ticker" href="/stock/pbmd#NASDAQ">PBMD</a>) shares touched a new 52-week low of $1.18. Prima Biomed's trailing-twelve-month ROE is -45.86%.

Hauppauge Digital (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>) shares tumbled 7.32% to touch a new 52-week low of $0.38. Hauppauge Digital shares have dropped 64.66% over the past 52 weeks, while the S&amp;P 500 index has gained 17.75% in the same period.

Baxano Surgical (NASDAQ: <a class="ticker" href="/stock/baxs#NASDAQ">BAXS</a>) shares reached a new 52-week low of $1.24. Baxano Surgical's PEG ratio is -0.14.

QC Holdings (NASDAQ: <a class="ticker" href="/stock/qcco#NASDAQ">QCCO</a>) shares tumbled 2.58% to reach a new 52-week low of $2.27. QC Holdings' trailing-twelve-month profit margin is 0.60%.

NewLead Holdings (NASDAQ: <a class="ticker" href="/stock/newl#NASDAQ">NEWL</a>) shares dipped 6.56% to touch a new 52-week low of $0.08 after the company completed the acquisition of titles in the Viking Mine located in Kentucky, USA.

Hauppauge Digital (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>) shares fell 8.70% to touch a new 52-week low of $0.42. Hauppauge Digital shares have dropped 61.02% over the past 52 weeks, while the S&amp;P 500 index has gained 18.17% in the same period.

Monroe Capital (NASDAQ: <a class="ticker" href="/stock/mrcc#NASDAQ">MRCC</a>) shares reached a new 52-week low of $13.09. Monroe Capital has a 52-week high of $15.46.

Hauppauge Digital, Inc. (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>) reports Q2 EPS of $(0.05).

Earnings

HaUppauge Digital, Inc. Reports Q2 EPS of $(0.05)

Below are highlights from Benzinga's daily coverage of small cap securities making big moves:

Novogen 

Shares of Novogen (NASDAQ: <a class="ticker" href="/stock/nvgn#NASDAQ">NVGN</a>), the Australian biotechnology company, rose 209% Tuesday on 8 times average volume.

Novogen announced Monday the results of an important study concerning its lead experimental drug, CS-6. In laboratory studies, CS-6 has shown potent anti-cancer activity against cancer cells representative of a broad range of malignancies including ovarian cancer and glioma (brain) cancer, but it was important to extend this to see whether the drug also would be effective against cancer stem cells. Such dual activity, unknown in all currently approved drugs and very rare among experimental drugs, would mark CS-6 as having significant potential as a comprehensive 
chemotherapy, targeting both the minority cancer stem cell as well as the majority non-stem cells.

Studies performed in the laboratory of Dr. Gil Mor at Yale University have identified and characterized ovarian cancer stem cells as the source of ovarian cancer recurrence. Targeting these cells, therefore, represent a critical approach to prevent recurrence, the main cause of mortality in patients with ovarian cancer. In laboratory tests conducted since Novogen acquired its new Triaxial drug technology, CS-6 has proved highly effective at stopping the growth of these cancer stem cells, eventually causing them to die.

Novogen closed at $6.47 on Tuesday.

MHI Hospitality

MHI Hospitality (NASDAQ: <a class="ticker" href="/stock/mdh#NASDAQ">MDH</a>), the Williamsburg, VA lodging real estate investment trust, rose 6% Tuesday on 27 times average volume.

MHI Hospitality reported Tuesday, its consolidated results for the fourth quarter and the year ended December 31, 2012. The Company generated adjusted EBITDA of approximately $4.6 million during the fourth quarter 2012, an increase of 26.4 percent or approximately $1.0 million over the comparable period in 2011. For the year 2012, the Company generated adjusted EBITDA of approximately $20.2 million, an increase of 18.4 percent or approximately $3.1 million over the prior year.

MHI Hospitality closed at $3.72 on Tuesday.

Hauppauge Digital

Shares of Hauppauge Digital (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>), the Hauppauge, NY developer of analog and digital video products for the personal computer (PC), and Apple iPad and iPhone, rose 45% Tuesday on 23 times average volume.

Hauppauge Digital released its 10-Q on Tuesday. Net sales for the three months ended December 31, 2012 decreased $3,496,849 compared to the three months ended December 31, 2011. The factors contributing to the gross profit percentage increase of 12.73% for the three months ended December 31, 2012 were primarily: 1) Favorable gross profit percentage due to mix of higher average sales price retail sales resulted in an increase of 0.91%. 2) A decrease in the Euro to USD exchange rate from $1.3479 for the three months ended December 31, 2011 to $1.2975 for the three months ended December 31, 2012 resulted in a gross profit decrease of 0.80%. 3) Labor related and other costs resulted in a gross profit decrease of 1.24% and 4) Change in estimates to reflect their current exposure resulted in a gross profit increase of 13.86%.

Hauppauge Digital closed at $1.02 on Tuesday.

The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment.

Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.

Long Ideas

Short Ideas

Small Cap

After-Hours Center

Movers

Tech

Trading Ideas

NVGN

Benzinga's Small Cap Movers for Tuesday February 19, 2013

Hauppauge Digital, Inc. (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>) reports Q4 EPS of $(0.16) versus $(0.21) in the same quarter last year. Revenue came in at $8.70M versus $10.30M a year ago.

HaUppauge Digital, Inc. Reports Q4 EPS of $(0.16), Up 24% YOY; Revenue of $8.70M, Down 16% YOY

Hauppauge Digital Trading 9.4% Higher on Heavy Volume; Currently at $1.51

Hauppauge Digital, Inc. (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>) has announced the release of StreamEez™, a high definition video streamer designed for organizations that want a simple to use, high quality video streamer to broadcast live events over the Internet. StreamEez was designed to serve as a powerful tool for any organization with live streaming needs; typical applications could include live streaming over the Internet for organizations sponsoring political events such as town hall meetings, church groups wanting to broadcast religious services and other groups that need a high quality live streaming solution.

The StreamEez box connects to an HD video camera using either HDMI or Component Video, compresses the camera's video using a built-in high quality H.264 encoder into a form that is compatible with many common streaming video sites such as USTREAM and Justin.tv. StreamEez then connects to a laptop computer (that is equipped with the Hauppauge StreamEez control application) via USB, making a connection to the streaming Internet website for live broadcast.

Contracts

Hauppauge Launches High Definition Video Streamer Designed To Broadcast Live Events Over The Internet 

Hauppauge Digital Trading 12.9% Higher on Heavy Volume; Currently at $1.4

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

Endocyte

Shares of Endocyte (NASDAQ: <a class="ticker" href="/stock/ecyt#NASDAQ">ECYT</a>), the West Lafayette, IN biopharmaceutical company, rose 100% Monday on 10 times the average daily volume.

Merck (NYSE: <a class="ticker" href="/stock/mrk#NYSE">MRK</a>) and Endocyte (NASDAQ: <a class="ticker" href="/stock/ecyt#NASDAQ">ECYT</a>) announced Monday that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide. Vintafolide is currently being evaluated in a Phase III clinical trial for platinum-resistant ovarian cancer, and a Phase II trial for non-small cell lung cancer; both studies are also using Endocyte's investigational companion diagnostic agent, etarfolatide.

Endocyte closed at $7.62 on Monday.

Hauppauge Digital 

Shares of Hauppauge Digital (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>), the Hauppauge, NY manufacturer of analog and digital TV tuner products for the personal computer, rose 37% Monday on 17 times the average daily volume.

Hauppauge Digital announced Monday that Broadway, Hauppauge's live TV streamer for the iPad and iPhone, now has TV recording support. With this new feature, Broadway can record TV programs locally and then stream it to an iPad or iPhone at a later time. "Broadway" is a stand alone "box" which allows live TV to be watched on an Apple device in the home through a Wi-Fi connection, or anywhere in the world via an Internet connection.

Broadway has a built-in over the air digital TV tuner, plus supports clear QAM digital cable TV and connections to cable or satellite set top boxes. Once connected to a TV source, Broadway can tune to a TV program and then either stream the live TV program to an iPad or iPhone, or, with the new feature, record the TV program to a locally attached storage device and then stream the recording at a later time.

Hauppauge Digital closed at $1.36 on Monday.

Vringo

Shares of Vringo (NASDAQ: <a class="ticker" href="/stock/vrng#NASDAQ">VRNG</a>), the New York City provider of software products for mobile video entertainment, personalization, and mobile social applications, rose 30% Monday on 8 times the average daily volume.

It was disclosed Friday that Mark Cuban had taken a 7.4% stake in Vringo.

Vringo closed at $3.97 on Monday.

ECYT

VRNG

Benzinga's Microcap Movers for Monday April 16, 2012

Hauppauge Digital Trading 67.2% Higher on Heavy Volume; Currently at $1.65

Hauppauge Digital, Inc. (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>) has announced that Broadway, Hauppauge's live TV streamer for the iPad and iPhone, now has TV recording support. With this new feature, Broadway can record TV programs locally and then stream it to an iPad or iPhone at a later time. "Broadway" is a stand alone "box" which allows live TV to be watched on an Apple device in the home through a Wi-Fi connection, or anywhere in the world via an Internet connection.

TV Recording Feature Added to Broadway, Hauppauge's TV Streamer 

Hauppauge Digital Spiking Higher on Heavy Volume; Currently at $1.18

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

Fonar Corporation

Shares of Fonar Corporation (NASDAQ: <a class="ticker" href="/stock/fonr#NASDAQ">FONR</a>), the Melville, NY magnetic resonance imaging company, rose 14% Tuesday on 99 times the average daily volume.

FONAR reported its financial results Tuesday for the second quarter of fiscal year 2012. For the three months ended December 31, 2011, net income increased 33% to $1.8 million, income from operations increased 31% to $1.9 million while total revenues increased 16% to $9.3 million, as compared to the corresponding fiscal quarter one year earlier.

The basic income per common share increased 56% to $0.50 for the six months ended December 31, 2011 as compared to $0.32 for the same period one year earlier. For the quarter ended December 31, 2011 and 2010, the basic net income per common share was $0.25.

Fonar Corporation closed at $2.22 on Tuesday.

Hauppauge Digital

Shares of Hauppauge Digital (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>), the Hauppauge, NY manufacturer, and marketing of analog and digital TV tuner products for the personal computer market, rose 41% Tuesday on 24 times the average daily volume.

Hauppauge Digital We recorded a net income of $443,932 for the three months ended December 31, 2011, which resulted in basic and diluted net income per share of $0.04 on weighted average basic and diluted shares of 10,122,344, compared to a net loss of $738,220 for the three months ended December 31, 2010, which resulted in basic and diluted net loss per share of $0.07 on weighted average basic and diluted shares of 10,083,417.

Hauppauge Digital closed at $1.50 on Tuesday.

NewLead Holdings

Shares of NewLead Holdings (NASDAQ: <a class="ticker" href="/stock/newl#NASDAQ">NEWL</a>), the Greek international shipping company, rose 85% Tuesday on 38 times the average daily volume.

A NewLead spokesperson could not be reached for comment, but the move was attributed to an overall strong shipping group.

NewLead Holdings closed at $1.13 on Tuesday.

Global

FONR

Benzinga's Microcap Movers for Tuesday February 14, 2012

Hauppauge Digital Trading 35% Higher on Earnings Beat; Currently at $1.43

View more <a href="http://sec.gov/Archives/edgar/data/930803/000114420412008479/v301292_10q.htm">here</a>

Hauppauge Digital Reports EPS $0.04 -Filing

Hauppague Spiking Higher on $0.04 vs ($0.07)

Rumors

Hauppague Digital RIses 40% on Renewed Chatter of Announcement at CES Next Week

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

Xoma

Shares of Xoma (NASDAQ: <a class="ticker" href="/stock/xoma#NASDAQ">XOMA</a>), the Berkeley, CA biopharmaceutical company, rose 0.81% Thursday on twice the average daily volume.

XOMA announced Thursday its Board of Directors has appointed John Varian as Chief Executive Officer. Mr. Varian has been serving as the Interim Chief Executive since August 31, 2011, and has been a member of the Board since December 2008. The Board's decision followed a full executive search, which identified several additional qualified candidates.

XOMA also announced it has implemented significant organizational and structural changes that are designed to sharpen the Company's focus on value-creating opportunities led by gevokizumab and the Company's unique antibody discovery and development capabilities.

XOMA plans to reduce personnel by 84 positions, or 34%, including 50 positions to be eliminated immediately and the remainder by the end of the first quarter of this year.

XOMA shares traded Thursday in a range of $1.14 to $1.38 and closed at $1.25.

Hauppauge Digital

Shares of Hauppauge Digital (NASDAQ: <a class="ticker" href="/stock/haup#NASDAQ">HAUP</a>), the Long Island, NY manufacturer and marketer of analog and digital TV tuner products for the personal computer, rose over 15% Thursday on 8 times the average daily volume.

There was chatter that the company may make a major product announcement at the CES show in Las Vegas next week. Benzinga was not able to get confirmation of the announcement from Hauppauge Digital.

Hauppauge Digital shares traded Thursday in a range of $0.71 to $0.93, closing at $0.89.

JBI

Shares of JBI (<a class="ticker" href="/stock/jbii#">JBII</a>), the Ontario, Canada green energy company, rose 46.51% Thursday on 23 times the average daily volume.

On Wednesday, the U.S. Securities and Exchange Commission, announced it filed an action in federal court in Massachusetts against JBI, its current CEO, John Bordynuik and former CFO, Ronald Baldwin, Jr. The action alleges that the defendants engaged in a scheme to commit securities and accounting fraud by reporting materially false and inaccurate financial information on the financial statements of JBI for two reporting periods during 2009.

The company responded to the SEC charges on Wednesday after the close of trading. The press release stated: "The allegations in the complaint concern legacy accounting issues that have since been corrected." 
 
JBI shares traded Thursday in a range of $0.52 to $1.40, closing at $1.26.

Legal

Management

JBII

XOMA

Benzinga's Microcap Movers for Thursday January 5, 2012

Hearing Chatter Hauppague Digital May Have Major Announcement at CES Show Next Week

Hauppauge Digital

Comments

Hauppauge Digital

Hauppauge Digital (HAUP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga